Beth Shaz, M.D., chief medical and scientific officer of Comprehensive Cell Solutions (CCS), a division of the New York Blood Center (NYBC), was featured in a recent issue of Genetic Engineering & Biotechnology News (GEN). The article (link below), “Streamlining Stem Cell Manufacturing,” delves deep into industry challenges and solutions to current hurdles in the stem cell supply chain. Dr. Shaz discusses the critical issues to consider when building this supply chain for regenerative medicine and stem cell products. Choosing a partner with expertise “in all aspects from collection to administration*” in addition to donor management is crucial and contributes to a customized plan for each company’s specific needs. This approach is key to CCS's goal of helping companies engineer and provide innovative, life-saving therapies to patients.